| scholarly article | Q13442814 |
| P50 | author | Christine L Le Maitre | Q39409436 |
| P2093 | author name string | Christopher Sammon | |
| Abbey A Thorpe | |||
| Joseph Snuggs | |||
| Louise Vickers | |||
| P2860 | cites work | The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration | Q24817050 |
| Molecular mechanisms of biological aging in intervertebral discs | Q26764941 | ||
| Role of cytokines in intervertebral disc degeneration: pain and disc content | Q27001658 | ||
| Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue | Q28270050 | ||
| Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes | Q28360073 | ||
| The global burden of low back pain: estimates from the Global Burden of Disease 2010 study | Q29394898 | ||
| Mineral deposition in the extracellular matrices of vertebrate tissues: identification of possible apatite nucleation sites on type I collagen | Q33666361 | ||
| The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors. | Q33726846 | ||
| Calcification in the ovine intervertebral disc: a model of hydroxyapatite deposition disease. | Q33972439 | ||
| Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties | Q34068369 | ||
| The pathophysiology of the intervertebral disc | Q34504785 | ||
| Crucial role of IL1beta and C3a in the in vitro-response of multipotent mesenchymal stromal cells to inflammatory mediators of polytrauma | Q35538801 | ||
| Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix | Q35963853 | ||
| Nutrition of the intervertebral disc | Q35963858 | ||
| Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration | Q36392322 | ||
| Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. | Q36392389 | ||
| What is intervertebral disc degeneration, and what causes it? | Q36568385 | ||
| Senescence in cells of the aging and degenerating intervertebral disc: immunolocalization of senescence-associated beta-galactosidase in human and sand rat discs | Q36724604 | ||
| Nucleus pulposus phenotypic markers to determine stem cell differentiation: fact or fiction? | Q36771759 | ||
| Matrix synthesis and degradation in human intervertebral disc degeneration. | Q36883824 | ||
| The cytokine and chemokine expression profile of nucleus pulposus cells: implications for degeneration and regeneration of the intervertebral disc. | Q37691242 | ||
| Cell death in intervertebral disc degeneration | Q38091320 | ||
| Ca(2+) signals, NAADP and two-pore channels: role in cellular differentiation | Q38202209 | ||
| Degeneration of the intervertebral disc with new approaches for treating low back pain. | Q38271248 | ||
| Cell-based therapies for intervertebral disc and cartilage regeneration- Current concepts, parallels, and perspectives | Q38814837 | ||
| Class 3 semaphorins expression and association with innervation and angiogenesis within the degenerate human intervertebral disc. | Q38842670 | ||
| Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration | Q38957636 | ||
| Thermally triggered hydrogel injection into bovine intervertebral disc tissue explants induces differentiation of mesenchymal stem cells and restores mechanical function | Q39158557 | ||
| Biochemical and structural properties of the cartilage end-plate and its relation to the intervertebral disc. | Q39286096 | ||
| Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration | Q40006569 | ||
| The structure and degradation of aggrecan in human intervertebral disc | Q41854830 | ||
| Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration | Q42163509 | ||
| Function of sustained released resveratrol on IL-1β-induced hBMSC MMP13 secretion inhibition and chondrogenic differentiation promotion. | Q42700206 | ||
| Hypertrophic differentiation and calcification during intervertebral disc degeneration. | Q42932253 | ||
| Nerves are more abundant than blood vessels in the degenerate human intervertebral disc. | Q43101289 | ||
| Senescence in human intervertebral discs | Q43167875 | ||
| Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc. | Q45189368 | ||
| Do intervertebral discs degenerate before they herniate, or after? | Q47876773 | ||
| Relative increase of biglycan and decorin and altered chondroitin sulfate epitopes in the degenerating human intervertebral disc. | Q50525024 | ||
| Thermally triggered injectable hydrogel, which induces mesenchymal stem cell differentiation to nucleus pulposus cells: Potential for regeneration of the intervertebral disc. | Q50868237 | ||
| Human cartilaginous endplate degeneration is induced by calcium and the extracellular calcium-sensing receptor in the intervertebral disc. | Q51619876 | ||
| Potential roles of cytokines and chemokines in human intervertebral disc degeneration: interleukin-1 is a master regulator of catabolic processes. | Q52837664 | ||
| Physical manipulation of calcium oscillations facilitates osteodifferentiation of human mesenchymal stem cells. | Q54559250 | ||
| Matrix Metalloproteinases And Aggrecanase | Q57539949 | ||
| Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration | Q59683291 | ||
| Micro-CT quantification of subchondral endplate changes in intervertebral disc degeneration | Q60977156 | ||
| Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc | Q61699189 | ||
| Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc | Q61699199 | ||
| Nerve growth factor expression and innervation of the painful intervertebral disc | Q61699202 | ||
| Analysis of Tissue Distribution of TNF- , TNF- -Receptors, and the Activating TNF- -Converting Enzyme Suggests Activation of the TNF- System in the Aging Intervertebral Disc | Q63341133 | ||
| Loads on the lumbar spine. Validation of a biomechanical analysis by measurements of intradiscal pressures and myoelectric signals | Q70373595 | ||
| Low back pain in relation to lumbar disc degeneration | Q73522106 | ||
| Nerve ingrowth into diseased intervertebral disc in chronic back pain | Q73570649 | ||
| Mechanical initiation of intervertebral disc degeneration | Q73931607 | ||
| Changes in mRNA and protein levels of proteoglycans of the anulus fibrosus and nucleus pulposus during intervertebral disc degeneration | Q78413360 | ||
| Differential regulation of matrix degrading enzymes in a TNFalpha-induced model of nucleus pulposus tissue degeneration | Q80171418 | ||
| 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells | Q83346462 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | e1055 | |
| P577 | publication date | 2019-06-26 | |
| P1433 | published in | JOR Spine | Q73541371 |
| P1476 | title | Mesenchymal stem cell therapies for intervertebral disc degeneration: Consideration of the degenerate niche | |
| P478 | volume | 2 |
| Q91601348 | Wnt3a and wnt5a as Potential Chondrogenic Stimulators for Nucleus Pulposus Cell Induction: A Comprehensive Review | cites work | P2860 |
Search more.